The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy
- PMID: 32690231
- PMCID: PMC7451584
- DOI: 10.1016/j.cjtee.2020.06.002
The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy
Abstract
COVID-19 is known for its magical infectivity, fast transmission and high death toll based on the large number of infected people. From the perspective of the clinical manifestation, autopsy examination and pathophysiology, the essence of COVID-19 should be viewed as a sepsis induced by viral infection, and has the essential characteristics as sepsis induced by other pathogens. Therefore, in addition to etiological and supportive treatment, immunomodulatory therapy is also appropriate to severe COVID-19. Although there is still a lack of consensus on immunotherapy for sepsis so far, relatively rich experiences have been accumulated in the past decades, which will help us in the treatment of severe COVID-19. This article will elaborate immunotherapy of sepsis, though it may not be consistent.
Keywords: COVID-19; Immunomodulatory therapy; Immunotherapy; Sepsis; Thymosin a1; Ulinastatin.
Copyright © 2020. Production and hosting by Elsevier B.V.
Conflict of interest statement
Declaration of Competing Interest The authors have no conflicts of interest relevant to this article.
Similar articles
-
Advice regarding COVID-19 and use of immunomodulators, in patients with severe dermatological diseases.Australas J Dermatol. 2020 May;61(2):158-159. doi: 10.1111/ajd.13295. Epub 2020 Apr 14. Australas J Dermatol. 2020. PMID: 32219857 Free PMC article. No abstract available.
-
Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic.J Eur Acad Dermatol Venereol. 2020 Jul;34(7):e302-e303. doi: 10.1111/jdv.16525. Epub 2020 Jun 4. J Eur Acad Dermatol Venereol. 2020. PMID: 32333823 Free PMC article. No abstract available.
-
Comparison of clinical laboratory tests between bacterial sepsis and SARS-CoV-2-associated viral sepsis.Mil Med Res. 2020 Aug 4;7(1):36. doi: 10.1186/s40779-020-00267-3. Mil Med Res. 2020. PMID: 32753048 Free PMC article.
-
Immunotherapies for COVID-19: lessons learned from sepsis.Lancet Respir Med. 2020 Oct;8(10):946-949. doi: 10.1016/S2213-2600(20)30217-4. Epub 2020 Apr 28. Lancet Respir Med. 2020. PMID: 32444269 Free PMC article. Review. No abstract available.
-
High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects.Front Immunol. 2020 Jul 14;11:1660. doi: 10.3389/fimmu.2020.01660. eCollection 2020. Front Immunol. 2020. PMID: 32760407 Free PMC article. Review.
Cited by
-
The role of SARS-COV-2 infection in promoting abnormal immune response and sepsis: A comparison between SARS-COV-2-related sepsis and sepsis from other causes.Infect Med (Beijing). 2023 Apr 28;2(3):202-211. doi: 10.1016/j.imj.2023.04.006. eCollection 2023 Sep. Infect Med (Beijing). 2023. PMID: 38073889 Free PMC article.
-
No causal association between COVID-19 and sepsis: a bidirectional two-sample Mendelian randomization study.Front Immunol. 2023 Oct 9;14:1183489. doi: 10.3389/fimmu.2023.1183489. eCollection 2023. Front Immunol. 2023. PMID: 37876930 Free PMC article.
-
Decoding Sepsis-Induced Disseminated Intravascular Coagulation: A Comprehensive Review of Existing and Emerging Therapies.J Clin Med. 2023 Sep 22;12(19):6128. doi: 10.3390/jcm12196128. J Clin Med. 2023. PMID: 37834771 Free PMC article. Review.
-
Clinical analysis of AN69ST membrane continuous venous hemofiltration in the treatment of severe sepsis.Open Med (Wars). 2023 Sep 12;18(1):20230784. doi: 10.1515/med-2023-0784. eCollection 2023. Open Med (Wars). 2023. PMID: 37724124 Free PMC article.
-
Ninety-day outcomes in patients diagnosed with COVID-19 in São Paulo, Brazil: a cohort study.J Bras Pneumol. 2023 Jun 5;49(3):e20230056. doi: 10.36416/1806-3756/e20230056. eCollection 2023. J Bras Pneumol. 2023. PMID: 37283402 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous